期刊文献+

深圳市宝安区1990-2007年流行性乙型脑炎流行特征分析 被引量:2

Analysis on Epidemic Characteristics of Epidemic Encephalitis B in Baoan District of Shenzhen
原文传递
导出
摘要 目的了解深圳市宝安区流行性乙型脑炎(乙脑)的流行情况,为乙脑的预防控制提供科学依据。方法利用传染病报告系统和乙脑监测系统报告数据,分析深圳市宝安区1990-2007年乙脑流行特征。结果深圳市宝安区1990-2007年共报告乙脑病例59例,死亡7例,乙脑年发病率为0~0.664/10万。乙脑发病集中在6-7月,占总病例数的86.40%;病例以散居儿童为主,≤9岁病例占86.40%;2003年以来的病例中66.60%的病例无免疫史或免疫史不详。结论预防控制乙脑应以抓好乙脑疫苗常规免疫接种为根本,建议每年在乙脑流行季节前开展乙脑疫苗查漏补种,重点做好农村和城郊地区的防蚊灭蚊工作,同时加强实验室监测。 Objective To understand the epidemic status of epidemic encephalitis B in Baoan District of Shenzhen, and to provide the scientific evidence for prevention and control of epidemic encephalitis B. Method The epidemic status of epidemic encephalitis B from 1990 to 2007 was analyzed by epidemic reporting system and encephalitis B monitoring system. Results There were 59 cases who suffered from encephalitis B in Baoan District of Shenzhen from 1990 to 2007, and 7 death cases occurred. The annual incidence of encephalitis B was 0-0. 664/100,000. There was a morbidity peak in June and July, which accounted for 86.40 % of the total incidence. Most of the cases were scattered children, the children aged ≤9 years accounted for 86.4 %. 66.696 of the cases had unclear or no history of immunization from 2003 to 2007. Conclusions The vaccination of encephalitis B vaccine is the key foundation to prevent and control encephalitis B. On the other hand, it is necessary to pay more attention to conducting supplementary encephalitis B immunization activities before the epidemic season of encephalitis B, killing and controlling mosquito in the country and suburb areas, and enhancing laboratory monitoring.
出处 《实用预防医学》 CAS 2009年第1期64-65,共2页 Practical Preventive Medicine
关键词 乙型脑炎 流行病学 防制 Encephalitis B Epidemiology Prevention and control
  • 相关文献

参考文献2

二级参考文献31

  • 1贾丽丽,郑铮,王志伟,俞永新.乙型脑炎减毒活疫苗(SA_(14)-14-2)在豚鼠体内保护作用的免疫机制的研究[J].微生物学免疫学进展,1995,23(2):73-76. 被引量:9
  • 2Xu YH, Zhaori GT, Vene S, et al. Viral etiology of acute child-hood encephalitis in Beijing diagnosed by analysis of single samples [J].Pediatr Infect Dis J, 1996,15:1018-1024.
  • 3Liu ZL, Hennessy S, Strom BL, et al. Short-term safety of live-attenuated Japanese encephalitis vaccine (SA14-14-2): Results of a 26,239-subject randomized trial [J]. J Infect Dis, 1997, 176: 1366-1369.
  • 4Kari K. personal communication.
  • 5Cardosa MJ, Hooi TP, Kaur P. Japanese encephalitis virus is animportant cause of encephalitis among children in Penang [J]. Southesat Asia J Trop Med Publ Health, 1995,26:272-275.
  • 6Kumar R, Mathur A, Kumar A. Clinical features and prognostic indicatiors of Japanese encephalitis in children in Lucknow (India)[J]. Indian J Med Res, 1990,91:321-327.
  • 7Joshi DD. Japanese encephalitis in Nepal[J]. Southeast Asian J Trop Med Publ Health, 1995,26:34-40.
  • 8Hoke CH, Nisalak A, Sangawhipa N, et al. Protection against Japanese encephalitis by inactivated vaccines [J]. N Engl J Med,1989,319:609-614.
  • 9Chow LP, Wei HY, Chen CL, et al. A controlled field trial for an evaluation of effectiveness of mouse-brain Japanese encephalitis vaccine[J]. J Formosa Med Assoc, 1971,70:55-61.
  • 10Okuno T, Tseng PT, Hsu ST, et al. Japanese encephalitis surveillance in China(Province of Taiwan)during 1958, 1971. Ⅱ. Age-specific incidence in connection with Japanese encephalitis vaccination program[J]. Jpn J Med Sci Biol, 1975,28:255-26.

共引文献49

同被引文献17

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部